Omjjara 100/150/200 mg film-coated tablets
*Company:
GlaxoSmithKline (Ireland) LtdStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 19 August 2024
File name
ie-pl-omjjara-issue1draft2-clean med.ie.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
Launch of Omjjara in Ireland, following EMA MA approval in January 2025.
Updated on 19 August 2024
File name
ie-spc-omjjara-issue1draft1-clean med.ie.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Launch of Omjjara in Ireland, following EMA MA approval in January 2025.